Literature DB >> 7885482

Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.

J Chen1, P K Jackson, M W Kirschner, A Dutta.   

Abstract

The protein p21 (WAF1, CIP1 or sdi1), induced by the tumour-suppressor protein p53, interacts with and inhibits two different targets essential for cell-cycle progression. One of these is the cyclin-Cdk family of kinases and the other is the essential DNA replication factor, proliferating-cell nuclear antigen (PCNA). We report here that separate domains of p21 are responsible for interacting with and inhibiting the two targets. An amino-terminal domain inhibits cyclin-Cdk kinases and a carboxy-terminal domain inhibits PCNA. Using these separated domains, we have determined that p21 inhibits different biological systems through different targets. The PCNA-binding domain is sufficient for inhibition of DNA replication based on simian virus 40, whereas the Cdk2-binding domain is sufficient for inhibition of DNA replication based on Xenopus egg extract and for growth suppression in transformed human cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7885482     DOI: 10.1038/374386a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  143 in total

Review 1.  Functional role of p21 during the cellular response to stress.

Authors:  M Gorospe; X Wang; N J Holbrook
Journal:  Gene Expr       Date:  1999

2.  Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death.

Authors:  A Suzuki; Y Tsutomi; N Yamamoto; T Shibutani; K Akahane
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  Functional analysis of cyclin-dependent kinase inhibitors of Arabidopsis.

Authors:  L De Veylder; T Beeckman; G T Beemster; L Krols; F Terras; I Landrieu; E van der Schueren; S Maes; M Naudts; D Inzé
Journal:  Plant Cell       Date:  2001-07       Impact factor: 11.277

Review 4.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

5.  p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein.

Authors:  S Shintani; H Ohyama; X Zhang; J McBride; K Matsuo; T Tsuji; M G Hu; G Hu; Y Kohno; M Lerman; R Todd; D T Wong
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

6.  G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells.

Authors:  April L Blajeski; Vy A Phan; Timothy J Kottke; Scott H Kaufmann
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

7.  Pattern of expression of p53, its family members, and regulators during early ocular development and in the post-mitotic retina.

Authors:  Linda Vuong; Daniel E Brobst; Anisse Saadi; Ivana Ivanovic; Muayyad R Al-Ubaidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-20       Impact factor: 4.799

8.  Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494.

Authors:  Jane N Winter; Shuli Li; Vikas Aurora; Daina Variakojis; Beverly Nelson; Maryla Krajewska; Lijun Zhang; Thomas M Habermann; Richard I Fisher; William R Macon; Mukesh Chhanabhai; Raymond E Felgar; Eric D Hsi; L Jeffrey Medeiros; James K Weick; Edie A Weller; Ari Melnick; John C Reed; Sandra J Horning; Randy D Gascoyne
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

9.  Mcm10 and And-1/CTF4 recruit DNA polymerase alpha to chromatin for initiation of DNA replication.

Authors:  Wenge Zhu; Chinweike Ukomadu; Sudhakar Jha; Takeshi Senga; Suman K Dhar; James A Wohlschlegel; Leta K Nutt; Sally Kornbluth; Anindya Dutta
Journal:  Genes Dev       Date:  2007-08-30       Impact factor: 11.361

10.  Cloning and characterization of the Xenopus cyclin-dependent kinase inhibitor p27XIC1.

Authors:  J Y Su; R E Rempel; E Erikson; J L Maller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.